Corrigendum: The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study
The authors wish to make the following corrections to their article: Efimov SV, Matsiyeuskaya NV, Boytsova OV, et al. Corrigendum: The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical stud...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BioExcel Publishing Ltd
2021-06-01
|
| Series: | Drugs in Context |
| Subjects: | |
| Online Access: | https://www.drugsincontext.com/corrigendum-the-effect-of-azoximer-bromide-polyoxidonium-in-patients-hospitalized-with-coronavirus-disease-covid-19-an-open-label-multicentre-interventional-clinical-study/ |
| _version_ | 1818668506359529472 |
|---|---|
| author | Sergey V Efimov Natallia V Matsiyeuskaya Olga V Boytsova Lyudmila Yu Akhieva Elena I Kvasova Francisco Harrison Yulia S Karpova Anton Tikhonov Nadezhda F Khomyakova Tim Hardman Jean-François Rossi |
| author_facet | Sergey V Efimov Natallia V Matsiyeuskaya Olga V Boytsova Lyudmila Yu Akhieva Elena I Kvasova Francisco Harrison Yulia S Karpova Anton Tikhonov Nadezhda F Khomyakova Tim Hardman Jean-François Rossi |
| author_sort | Sergey V Efimov |
| collection | DOAJ |
| description | The authors wish to make the following corrections to their article:
Efimov SV, Matsiyeuskaya NV, Boytsova OV, et al. Corrigendum: The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study. Drugs in Context 2021; 10: 2021-11-1. DOI: 10.7573/dic.2020-11-1 |
| first_indexed | 2024-12-17T06:37:24Z |
| format | Article |
| id | doaj.art-377c8f9e5bd0480cba49308b548b1f5b |
| institution | Directory Open Access Journal |
| issn | 1740-4398 1740-4398 |
| language | English |
| last_indexed | 2024-12-17T06:37:24Z |
| publishDate | 2021-06-01 |
| publisher | BioExcel Publishing Ltd |
| record_format | Article |
| series | Drugs in Context |
| spelling | doaj.art-377c8f9e5bd0480cba49308b548b1f5b2022-12-21T21:59:57ZengBioExcel Publishing LtdDrugs in Context1740-43981740-43982021-06-01101210.7573/dic.2021-5-2Corrigendum: The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical studySergey V EfimovNatallia V MatsiyeuskayaOlga V BoytsovaLyudmila Yu AkhievaElena I KvasovaFrancisco HarrisonYulia S KarpovaAnton TikhonovNadezhda F Khomyakova Tim HardmanJean-François RossiThe authors wish to make the following corrections to their article: Efimov SV, Matsiyeuskaya NV, Boytsova OV, et al. Corrigendum: The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study. Drugs in Context 2021; 10: 2021-11-1. DOI: 10.7573/dic.2020-11-1https://www.drugsincontext.com/corrigendum-the-effect-of-azoximer-bromide-polyoxidonium-in-patients-hospitalized-with-coronavirus-disease-covid-19-an-open-label-multicentre-interventional-clinical-study/azoximer bromide (polyoxidonium®)covid-19inflammationinterventional study |
| spellingShingle | Sergey V Efimov Natallia V Matsiyeuskaya Olga V Boytsova Lyudmila Yu Akhieva Elena I Kvasova Francisco Harrison Yulia S Karpova Anton Tikhonov Nadezhda F Khomyakova Tim Hardman Jean-François Rossi Corrigendum: The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study Drugs in Context azoximer bromide (polyoxidonium®) covid-19 inflammation interventional study |
| title | Corrigendum: The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study |
| title_full | Corrigendum: The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study |
| title_fullStr | Corrigendum: The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study |
| title_full_unstemmed | Corrigendum: The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study |
| title_short | Corrigendum: The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study |
| title_sort | corrigendum the effect of azoximer bromide polyoxidonium r in patients hospitalized with coronavirus disease covid 19 an open label multicentre interventional clinical study |
| topic | azoximer bromide (polyoxidonium®) covid-19 inflammation interventional study |
| url | https://www.drugsincontext.com/corrigendum-the-effect-of-azoximer-bromide-polyoxidonium-in-patients-hospitalized-with-coronavirus-disease-covid-19-an-open-label-multicentre-interventional-clinical-study/ |
| work_keys_str_mv | AT sergeyvefimov corrigendumtheeffectofazoximerbromidepolyoxidoniuminpatientshospitalizedwithcoronavirusdiseasecovid19anopenlabelmulticentreinterventionalclinicalstudy AT natalliavmatsiyeuskaya corrigendumtheeffectofazoximerbromidepolyoxidoniuminpatientshospitalizedwithcoronavirusdiseasecovid19anopenlabelmulticentreinterventionalclinicalstudy AT olgavboytsova corrigendumtheeffectofazoximerbromidepolyoxidoniuminpatientshospitalizedwithcoronavirusdiseasecovid19anopenlabelmulticentreinterventionalclinicalstudy AT lyudmilayuakhieva corrigendumtheeffectofazoximerbromidepolyoxidoniuminpatientshospitalizedwithcoronavirusdiseasecovid19anopenlabelmulticentreinterventionalclinicalstudy AT elenaikvasova corrigendumtheeffectofazoximerbromidepolyoxidoniuminpatientshospitalizedwithcoronavirusdiseasecovid19anopenlabelmulticentreinterventionalclinicalstudy AT franciscoharrison corrigendumtheeffectofazoximerbromidepolyoxidoniuminpatientshospitalizedwithcoronavirusdiseasecovid19anopenlabelmulticentreinterventionalclinicalstudy AT yuliaskarpova corrigendumtheeffectofazoximerbromidepolyoxidoniuminpatientshospitalizedwithcoronavirusdiseasecovid19anopenlabelmulticentreinterventionalclinicalstudy AT antontikhonov corrigendumtheeffectofazoximerbromidepolyoxidoniuminpatientshospitalizedwithcoronavirusdiseasecovid19anopenlabelmulticentreinterventionalclinicalstudy AT nadezhdafkhomyakova corrigendumtheeffectofazoximerbromidepolyoxidoniuminpatientshospitalizedwithcoronavirusdiseasecovid19anopenlabelmulticentreinterventionalclinicalstudy AT timhardman corrigendumtheeffectofazoximerbromidepolyoxidoniuminpatientshospitalizedwithcoronavirusdiseasecovid19anopenlabelmulticentreinterventionalclinicalstudy AT jeanfrancoisrossi corrigendumtheeffectofazoximerbromidepolyoxidoniuminpatientshospitalizedwithcoronavirusdiseasecovid19anopenlabelmulticentreinterventionalclinicalstudy |